Serum endostatin levels in patients with hepatocellular carcinoma
Authors:
- M. YamagataMYM. Yamagata
- Y. ShiratoriYSY. Shiratori
- Y. DanYDY. Dan
- S. ShiinaSSS. Shiina
- T. TakayamaTTT. Takayama
- M. MakuuchiMMM. Makuuchi
- M. OmataMOM. Omata
Open Access
- 1 June 2000
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 11 (6) , 761-762
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Serum Concentrations of Endostatin in Patients with Vulvar CancerGynecologic Oncology, 1999
- Structure, function and tissue forms of the C‐terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatinThe EMBO Journal, 1998
- Antiangiogenic therapy of experimental cancer does not induce acquired drug resistanceNature, 1997
- Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and plateletsProceedings of the National Academy of Sciences, 1997
- Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor GrowthCell, 1997
- Vascular Endothelial Growth Factor Is a Secreted Angiogenic MitogenScience, 1989